Broadway Financial Corp (BYFC) stock analysis
Close on Nov 11, 2026Market cap $106.89MP/E –Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Weak4 of 30 checks passed
Broadway Financial passes 4 of the 30 checks behind our score; 17 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 1/6
- Growth
- 1/6
- Past performance
- 0/6
- Financial health
- 2/6
- Dividend
- 0/6
What stands out
Well capitalized
Equity is 16.8% of total assets; 8% or more is a comfortable cushion.
P/B below the industry
Broadway Financial's price-to-book of 0.41 is below the Savings Institutions median of 1.04.
Growing faster than the industry
Revenue grew 16.8% over the last twelve months; the Savings Institutions median is 9.0%.
Deposits growing
Deposits grew 39.5% over the past year.
What to watch
Return on equity under 15%
Return on equity was -7.6% over the last twelve months and averaged -1.7% over five years; we look for 15% on both.
Revenue growing under 10% a year
Revenue grew 8.3% a year over the last three fiscal years, short of the 10% we look for.
P/S above the industry
Broadway Financial's price-to-sales of 568.56 is above the Savings Institutions median of 3.77.
Return on assets under 1%
Return on assets was -1.5%; for a bank or insurer, 1% or more is considered good.
Valuation1/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
P/S above the industry
Broadway Financial's price-to-sales of 568.56 is above the Savings Institutions median of 3.77.
P/B below the industry
Broadway Financial's price-to-book of 0.41 is below the Savings Institutions median of 1.04.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth1/6
Revenue growing under 10% a year
Revenue grew 8.3% a year over the last three fiscal years, short of the 10% we look for.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing faster than the industry
Revenue grew 16.8% over the last twelve months; the Savings Institutions median is 9.0%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
Banks and insurers do not report gross profit.
Past performance0/6
Return on equity under 15%
Return on equity was -7.6% over the last twelve months and averaged -1.7% over five years; we look for 15% on both.
Return on assets under 1%
Return on assets was -1.5%; for a bank or insurer, 1% or more is considered good.
Return on equity below the industry
Broadway Financial's return on equity of -7.6% is below the Savings Institutions median of 6.1%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin below its 5-year average
Net margin was -11027% over the last twelve months, against a 5-year average of -1511%.
Net margin below the industry
Broadway Financial's net margin of -11027% is below the Savings Institutions median of 20.3%.
Financial health2/6
Well capitalized
Equity is 16.8% of total assets; 8% or more is a comfortable cushion.
Loans funded by deposits
Needs loans and deposits.
Adequate loan-loss reserve
The allowance for credit losses is not reported.
High cost base
Non-interest expense takes 143% of revenue; under 60% is efficient for a bank.
Deposits growing
Deposits grew 39.5% over the past year.
Borrowings
Needs debt and equity figures.
Dividend0/6
No dividend
Broadway Financial has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itWe don't publish a fair value for Broadway Financial. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 16.6
- Savings Institutions median 13.7
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
High risk
- Average value traded per day
- $29.46K
- Value traded per 1% price move
- $14.38K
Downside
Low risk
- Typical loss in a bad month
- 7.3%
- Volatility (annualized)
- 41%
- Sharpe ratio, 1 year
- 1.88
- Beta to the S&P 500 (5Y)
- 0.76
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +18.7% | +8.3% | -15.2% | -35.2% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 7.6% | -1.3% | -9.1% | |
| Return on assets | 0.8% | -0.1% | -1.9% | |
| Capex to revenue | 1.3% | 98.8% | 132.1% | |
| Diluted shares | 4M | 3M | 9M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Broadway Financial generated $16.17M from operations and spent $2.05M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -13475.5% | 0.00× | 4.89× | -9.1% |
| FY2024 | 1244.5% | 0.00× | 4.84× | 0.7% |
| FY2023 | 2417.3% | 0.00× | 4.62× | 1.5% |
| FY2022 | 3886.9% | 0.00× | 5.42× | 2.7% |
| FY2021 | -1626.5% | 0.00× | 8.30× | -4.3% |
| FY2020 | -152.9% | 0.00× | 9.45× | -1.3% |
| FY2019 | -42.0% | 0.00× | 8.73× | -0.4% |
| FY2018 | 181.5% | 0.00× | 8.56× | 1.7% |
| FY2017 | 419.1% | 0.00× | 9.04× | 4.0% |
| FY2016 | 27.9% | 0.03× | 9.07× | 7.6% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero-$24.80M
- Cash generatingOperating cash flow above zero$230.00K
- Return on assets improvedROA up on the prior year0.1% → -1.9%
- Earnings backed by cashOperating cash flow above net income$230.00K vs -$24.80M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise9M → 9M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.00 → 0.00
See a number that looks wrong?